{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:02:57Z","timestamp":1792036977357,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1038\/ng0696-233","type":"journal-article","created":{"date-parts":[[2004,8,18]],"date-time":"2004-08-18T20:18:55Z","timestamp":1092860335000},"page":"233-237","source":"Crossref","is-referenced-by-count":445,"title":["Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia"],"prefix":"10.1038","volume":"13","author":[{"given":"Michael C.","family":"Naski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Ornitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFng0696233_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/jmg.16.2.140","volume":"16","author":"R Oberklaid","year":"1979","unstructured":"Oberklaid, R., Danks, D.M., Jensen, F., Stace, L. & Rosshandler, S. Achondroplasia and hypochondroplasia. Comments on frequencey, mutation rate, and radiological features in skull and spine. J. Med. Genet. 16, 140\u2013146 (1979).","journal-title":"J. Med. Genet."},{"key":"BFng0696233_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0344-0338(11)80783-1","volume":"187","author":"J Briner","year":"1991","unstructured":"Briner, J., Giedion, A. & Spycher, M.A. Variation of quantitative and qualitative changes of enchondral ossification in heterozygous achondroplasia. Pathol. Res. Pract. 187, 271\u2013278 (1991).","journal-title":"Pathol. Res. Pract."},{"key":"BFng0696233_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/jmg.10.3.243","volume":"10","author":"K Shah","year":"1973","unstructured":"Shah, K., Astley, R. & Cameron, A.H. Thanatophoric dwarfism. J. Med. Genet. 10, 243\u2013252 (1973).","journal-title":"J. Med. Genet."},{"key":"BFng0696233_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng0395-321","volume":"9","author":"PL Tavormina","year":"1995","unstructured":"Tavormina, P.L. et al.Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet. 9, 321\u2013328 (1995).","journal-title":"Nature Genet."},{"key":"BFng0696233_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/371252a0","volume":"371","author":"F Rousseau","year":"1994","unstructured":"Rousseau, F. et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252\u2013254 (1994).","journal-title":"Nature"},{"key":"BFng0696233_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","volume":"78","author":"R Shiang","year":"1994","unstructured":"Shiang, R. et al. Mutations in the transmembrane domain of FGFRS cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 335\u2013342 (1994).","journal-title":"Cell"},{"key":"BFng0696233_CR7","unstructured":"Rimoin, D.L. & Lachman, R.S. Genetic disorders of the osseous skeleton, in McKusick's Heritable Disorders of connective tissue. (ed. Beighton, R) 557\u2013689 (Mosby-Year Book, St. Louis, 1993)."},{"key":"BFng0696233_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/MCB.12.1.240","volume":"12","author":"DM Ornitz","year":"1992","unstructured":"Ornitz, D.M., Yayon, A., Flanagan, J.G., Svahn, C.M., Levi, E. & Leder, P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12, 240\u2013247 (1992).","journal-title":"Mol. Cell. Biol."},{"key":"BFng0696233_CR9","doi-asserted-by":"crossref","first-page":"16305","DOI":"10.1016\/S0021-9258(18)42001-7","volume":"267","author":"DM Ornitz","year":"1992","unstructured":"Ornitz, D.M. & Leder, P. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267, 16305\u201316311 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFng0696233_CR10","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1016\/S0021-9258(19)78170-8","volume":"269","author":"AT Chellaiah","year":"1994","unstructured":"Chellaiah, A.T., McEwen, D.G., Werner, S., Xu, J. & Ornitz, D.M. Fibroblast Growth Factor Receptor (FGFR) 3: Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF\/FGF-1. J. Biol. Chem. 269, 11620\u201311627 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFng0696233_CR11","first-page":"2229","volume":"6","author":"K Keegan","year":"1991","unstructured":"Keegan, K., Meyer, S. & Hayman, M.J. Structural and biosynthetic characterization of the fibroblast growth factor receptor 3 (FGFR-3) protein. Oncogene 6, 2229\u20132236 (1991).","journal-title":"Oncogene"},{"key":"BFng0696233_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0092-8674(86)90779-8","volume":"45","author":"CI Bargmann","year":"1986","unstructured":"Bargmann, C.I., Hung, M.-C. & Weinberg, R.A. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45, 649\u2013657 (1986).","journal-title":"Cell"},{"key":"BFng0696233_CR13","doi-asserted-by":"publisher","first-page":"26037","DOI":"10.1074\/jbc.270.44.26037","volume":"270","author":"KM Neilson","year":"1995","unstructured":"Neilson, K.M. & Friesel, R.E. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270, 26037\u201326040 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFng0696233_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.7824936","volume":"267","author":"M Santoro","year":"1995","unstructured":"Santoro, M. et al. Activation of RET as a dominant transforming gene by germline mutatins of MEN2A and MEN2B. Science 267, 381\u2013383 (1995).","journal-title":"Science"},{"key":"BFng0696233_CR15","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1016\/S0021-9258(17)36947-8","volume":"269","author":"A Sorokin","year":"1994","unstructured":"Sorokin, A., Lemmon, M.A., Ullrich, A. & Schlessinger, J. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. J. Biol. Chem. 269, 9752\u20139759 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFng0696233_CR16","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1128\/MCB.14.6.3535","volume":"14","author":"SS Watowich","year":"1994","unstructured":"Watowich, S.S., Hilton, D.J. & Lodish, H.F. Activation and inhibition of erythropoietin receptor function: Role of receptor dimerization. Mol. Cell. Biol. 14, 3535\u20133549 (1994).","journal-title":"Mol. Cell. Biol."},{"key":"BFng0696233_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0092-8674(95)90455-7","volume":"80","author":"JM Blechman","year":"1995","unstructured":"Blechman, J.M. et al. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell 80, 103\u2013113 (1995).","journal-title":"Cell"},{"key":"BFng0696233_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1126\/science.1549776","volume":"255","author":"AM De Vos","year":"1992","unstructured":"De Vos, A.M., Ultscyh, M. & Kossiakoff, A.A. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255, 306\u2013312 (1992).","journal-title":"Science"},{"key":"BFng0696233_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0168-9525(00)89088-5","volume":"11","author":"M Muenke","year":"1995","unstructured":"Muenke, M. & Schell, U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends. Genet. 11, 308\u2013313 (1995).","journal-title":"Trends. Genet."},{"key":"BFng0696233_CR20","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0960-9822(95)00102-3","volume":"5","author":"AOM Wilkie","year":"1995","unstructured":"Wilkie, A.O.M., Morriss-Kay, G.M., Jones, E.Y. & Heath, J.K. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5, 500\u2013507 (1995).","journal-title":"Curr. Biol."},{"key":"BFng0696233_CR21","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1128\/MCB.16.3.977","volume":"16","author":"M Mohammadi","year":"1996","unstructured":"Mohammadi, M., Dikic, I., Sorokin, A., Burgess, W.H., Jaye, M. & Schlessinger, J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16, 977\u2013989 (1996).","journal-title":"Mol. Cell. Biol."},{"key":"BFng0696233_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1126\/science.3291115","volume":"241","author":"SK Hanks","year":"1988","unstructured":"Hanks, S.K., Quinn, A.M. & Hunter, T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42\u201352 (1988).","journal-title":"Science"},{"key":"BFng0696233_CR23","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(18)53525-0","volume":"268","author":"P Formisano","year":"1993","unstructured":"Formisano, P. et al. Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action. J. Biol. Chem. 268, 5241\u20135248 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFng0696233_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/372746a0","volume":"372","author":"SR Hubbard","year":"1994","unstructured":"Hubbard, S.R., Wei, L., Ellis, L. & Hendrickson, W.A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746\u2013754 (1994).","journal-title":"Nature"},{"key":"BFng0696233_CR25","doi-asserted-by":"publisher","first-page":"9170","DOI":"10.1073\/pnas.91.19.9170","volume":"91","author":"A Hanneken","year":"1994","unstructured":"Hanneken, A., Ying, W., Ling, N. & Baird, A. Identification of soluble forms of the fibroblast growth factor receptor in blood. Proc. Natl. Acad. Sci. USA 91, 9170\u20139174 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng0696233_CR26","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1101\/gad.8.11.1311","volume":"8","author":"RAW Rupp","year":"1994","unstructured":"Rupp, R.A.W., Snider, L. & Weintraub, H. Xenopus embryos regulate the nuclear localization of XMyoD. Genes Dev. 8, 1311\u20131323 (1994).","journal-title":"Genes Dev."},{"key":"BFng0696233_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1083\/jcb.110.2.503","volume":"110","author":"BB Olwin","year":"1990","unstructured":"Olwin, B.B. & Hauschka, S.D. Fibroblast growth factor receptor levels decrease during chick embryogenesis. J. Cell Biol. 110, 503\u2013509 (1990).","journal-title":"J. Cell Biol."},{"key":"BFng0696233_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/j.1460-2075.1996.tb00384.x","volume":"15","author":"MK Webster","year":"1996","unstructured":"Webster, M.K. & Donoghue, D.J Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15, 520\u2013527 (1996).","journal-title":"EMBO J."},{"key":"BFng0696233_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ng0496-390","volume":"12","author":"JS Colvin","year":"1996","unstructured":"Colvin, J.S., Bohne, B.A., Harding, G.W., McEwen, D.G. & Ornitz, D.M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet. 12, 390\u2013397 (1996).","journal-title":"Nature Genet."},{"key":"BFng0696233_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","volume":"84","author":"C Deng","year":"1996","unstructured":"Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A & Leder, P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911\u2013921 (1996).","journal-title":"Cell"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng0696-233","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0696-233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0696-233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:41:31Z","timestamp":1684442491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng0696-233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["BFng0696233"],"URL":"https:\/\/doi.org\/10.1038\/ng0696-233","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}